DEVIN WHITT: Open Payments
NPI 1821627068 · WHITESBURG, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$812 in 40 payments from 12 companies in 2025. Trend: 2023 $1,219 · 2024 $1,164 · 2025 $812
Food & beverage: $812
| Company | Payments | Amount |
|---|---|---|
| Grifols USA, LLC | 10 | $217 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $148 |
| Viatris Specialty LLC | 5 | $90 |
| Verona Pharma, Inc. | 5 | $90 |
| AstraZeneca Pharmaceuticals LP | 3 | $86 |
| Regeneron Healthcare Solutions, Inc. | 2 | $38 |
| Merck Sharp & Dohme LLC | 2 | $37 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $23 |
| Exact Sciences Corporation | 1 | $23 |
| Pulmonx Corporation | 1 | $22 |
Products named: Prolastin-C Liquid, GLASSIA, YUPELRI, Ohtuvayre, ARALAST, AIRSUPRA, DUPIXENT, ZERBAXA.
Industry payments across KY — which companies pay providers there.
